Literature DB >> 8887541

Ras signaling in tumor necrosis factor-induced apoptosis.

J C Trent1, D J McConkey, S M Loughlin, M T Harbison, A Fernandez, H N Ananthaswamy.   

Abstract

Tumor necrosis factor (TNF) exerts cytotoxicity on many types of tumor cells but not on normal cells. The molecular events leading to cell death triggered by TNF are still poorly understood. Our previous studies have shown that enforced expression of an activated H-ras oncogene converted non-tumorigenic, TNF-resistant C3H 10T1/2 fibroblasts into tumorigenic cells that also became very sensitive to TNF-induced apoptosis. This finding suggested that Ras activation may play a role in TNF-induced apoptosis. In this study we investigated whether Ras activation is an obligatory step in TNF-induced apoptosis. Introduction of two different molecular antagonists of Ras, the rap1A tumor suppressor gene or the dominant-negative rasN17 gene, into H-ras-transformed 10TEJ cells inhibited TNF-induced apoptosis. Similar results were obtained with L929 cells, a fibroblast cell line sensitive to TNF-induced apoptosis, which does not have a ras mutation. While Ras is constitutively activated in TNF-sensitive 10TEJ cells, TNF treatment increased Ras-bound GTP in TNF-sensitive L929 cells but not in TNF-resistant 10T1/2 cells. Moreover, RasN17 expression blocked TNF-induced Ras-GTP formation in L929 cells. These results demonstrate that Ras activation is required for TNF-induced apoptosis in mouse fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887541      PMCID: PMC452179     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  39 in total

1.  Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras.

Authors:  D W Stacey; L A Feig; J B Gibbs
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

2.  A ras-related gene with transformation suppressor activity.

Authors:  H Kitayama; Y Sugimoto; T Matsuzaki; Y Ikawa; M Noda
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

3.  Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF.

Authors:  M J Chen; B Holskin; J Strickler; J Gorniak; M A Clark; P J Johnson; M Mitcho; D Shalloway
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

4.  Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division.

Authors:  C A Reznikoff; D W Brankow; C Heidelberger
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

5.  Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.

Authors:  H Adari; D R Lowy; B M Willumsen; C J Der; F McCormick
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

6.  Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines.

Authors:  L M Green; J L Reade; C F Ware
Journal:  J Immunol Methods       Date:  1984-05-25       Impact factor: 2.303

Review 7.  Cachectin and tumour necrosis factor as two sides of the same biological coin.

Authors:  B Beutler; A Cerami
Journal:  Nature       Date:  1986 Apr 17-23       Impact factor: 49.962

8.  Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

Authors:  M Y Kim; C Linardic; L Obeid; Y Hannun
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

9.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

Authors:  B J Sugarman; B B Aggarwal; P E Hass; I S Figari; M A Palladino; H M Shepard
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

10.  Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression.

Authors:  A H Wyllie; K A Rose; R G Morris; C M Steel; E Foster; D A Spandidos
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

View more
  13 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  Histopathological evaluation of apoptosis in cancer.

Authors:  Y Soini; P Pääkkö; V P Lehto
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

3.  Inhibition of apoptosis by the actin-regulatory protein gelsolin.

Authors:  M Ohtsu; N Sakai; H Fujita; M Kashiwagi; S Gasa; S Shimizu; Y Eguchi; Y Tsujimoto; Y Sakiyama; K Kobayashi; N Kuzumaki
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

4.  Tumor necrosis factor alpha activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary cultures of neurons.

Authors:  G Barbin; M P Roisin; B Zalc
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

5.  Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death.

Authors:  P Dent; D B Reardon; J S Park; G Bowers; C Logsdon; K Valerie; R Schmidt-Ullrich
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

6.  Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38.

Authors:  Janice C Wolfman; Todd Palmby; Channing J Der; Alan Wolfman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

7.  Modulation of tumor necrosis factor-mediated cell death by fullerenes.

Authors:  Ljubica Harhaji; Aleksandra Isakovic; Ljubica Vucicevic; Kristina Janjetovic; Maja Misirkic; Zoran Markovic; Biljana Todorovic-Markovic; Nadezda Nikolic; Sanja Vranjes-Djuric; Zoran Nikolic; Vladimir Trajkovic
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

8.  Pro-apoptotic activity of oncogenic H-Ras for histone deacetylase inhibitor to induce apoptosis of human cancer HT29 cells.

Authors:  Shambhunath Choudhary; Hwa-Chain Robert Wang
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-04       Impact factor: 4.553

9.  Ceramide inhibits inwardly rectifying K+ currents via a Ras- and Raf-1-dependent pathway in cultured oligodendrocytes.

Authors:  H Hida; M Takeda; B Soliven
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

10.  The inside mystery of jejunal gastrointestinal stromal tumor: a rare case report and review of the literature.

Authors:  A K Dhull; V Kaushal; R Dhankhar; R Atri; H Singh; N Marwah
Journal:  Case Rep Oncol Med       Date:  2011-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.